Cencora, Inc. (COR)

From the record

Cencora, Inc.'s filings since 2017 show 2 warning events: a material cybersecurity incident (8-K item 1.05, 2 times, the latest 2024-07-31) (its current reports).

From the record

Cencora, Inc.'s 10 filed years say what it did: revenue went from $147 billion in fiscal 2016 to $321 billion in fiscal 2025, up 9.1% a year; it rose in 9 of 9 years; it never fell from a peak; net income was positive in 9 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-09-30, Cencora, Inc.'s diluted share count shrank about 2.6% a year, and dividends and buybacks returned about 39% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 13 sales (8 under scheduled 10b5-1 plans) and 3 purchases of their own stock on the open market in the year to 2026-11-10, buying about $2 million (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-09-30, Cencora, Inc. earned about 103 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 15 cents per dollar of everything the company owns. Leverage: it owed about 98 cents per dollar of assets, and net share issuance: its share count shrank 2.5% over the year (the filed statements).

From the record

Cencora, Inc.'s standing among 10 graded names in its industry family: revenue of $321 billion in fiscal 2025 ranks in the top 15% by size; a net margin of 0.5% ranks in the top 45%; revenue growth of 10.4% a year over the last 3 filed years ranks in the top 35% (its annual reports).

From the record

Cencora, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Mauch, Robert P. (President & CEO, as filed), filing under that title since 2024-11-13, 2 years (top 50% of its family); the 19 officers and directors filing in the last fifteen months have been on the record a median of 4.1 years (bottom 36%); 15 officer or director changes were reported on Form 8-K since 2023-11-13, against the 19 people in charge now (bottom 39%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Cencora, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $4.4 billion against debt of $7.5 billion leaves -4.2% of its assets as net cash, top 45% of its family; cash from operations less capital spending is 1% of revenue (bottom 45%); a gross margin of 3.6% (bottom 15%) (its annual report).

From the record

Cencora, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 10.4% a year over the last three filed years against 9.1% over all 10, speeding up (top 19% of its family); the newest year grew 9.3% (bottom 44%); capital spending grew 10.4% a year (top 19%) (its annual reports). Cencora, Inc. reported 2 lines of business in fiscal 2025: US Healthcare Solutions at $285 billion, International Healthcare Solutions at $28 billion. 2 of 2 grew in the latest filed year, and the largest line is 91% of revenue (its annual report).

From the record

Cencora, Inc.'s newest year against its own record: revenue of $321 billion in fiscal 2025 came in 1.5% below the $326 billion its prior three years' pace pointed to (bottom 36% of its family); net income of $1.6 billion against a prior three-year average of $1.7 billion (bottom 36%); a net margin of 0.5% against 0.6% before (bottom 36%) (its annual reports).